Screener
Sionna Therapeutics SION PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Sionna Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033876
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Marketable securities, current | 152,826 | 177,431 |
| Prepaid expenses and other current assets | 4,809 | 5,537 |
| Total current assets | 220,959 | 241,419 |
| Property and equipment, net | 2,071 | 2,225 |
| Marketable securities, noncurrent | 73,781 | 74,420 |
| Restricted cash | 963 | 963 |
| Operating lease right-of-use asset | 6,680 | 6,926 |
| Other assets | 585 | — |
Item 1. Financial Statements
FAQ
- What is Sionna Therapeutics's PP&E (net)?
- Sionna Therapeutics (SION) reported PP&E (net) of $2.07M in Q1 2026.
- How has Sionna Therapeutics's PP&E (net) changed year-over-year?
- Sionna Therapeutics's PP&E (net) decreased by 13.5% year-over-year, from $2.39M to $2.07M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Sionna Therapeutics's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude